• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX?; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX?; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number M635WU50270
Medical Device Problem Codes Migration (4003); Failure to Seal (4070)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/08/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a device leak and implant movement/shift occurred.A left atrial appendage (laa) closure procedure was performed, and a 27mm watchman flx closure device was successfully implanted on (b)(6) 2024.The patient was discharged.During a routine 45-day follow-up on (b)(6) 2024, it was noted there was a leak due to closure device shifting.No information was provided at that time.The leak was below the fabric and had not endothelialized.A computed tomography (ct) was performed after multiple transesophageal echocardiography's.The patient remains on warfarin.There were no patient complications.
 
Additional Manufacturer Narrative
With all the available information, boston scientific (bsc) concludes: device technical analysis: the watchman flx? remains implanted; therefore, returned device analysis could not be completed.Media review: the provided medical media was captured during a follow up appointment and does not require further review by a bsc medical safety representative.Device history record review: a review was completed of the device history records (dhr) for the watchman flx? part # m635wu50270 batch # 0032678263.The device was processed through all normal operational conditions and passed all acceptance activities.The dhr review did not identify any deviations or non-conformances that could have contributed to the event.Labeling review: there was no evidence to suggest that the device was used in a manner inconsistent with the labeling.Watchman flx? instructions for use (ifu) lists potential complications, risks and adverse events that may be associated with the use of this device which include implant did not seal and implant movement/shift (medication and imaging required).Risk review: a risk review was completed and confirmed that the events of implant did not seal, and implant movement/shift were defined in the risk documentation.These event types have been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Event or Problem Description
It was reported that a device leak and implant movement/shift occurred.A left atrial appendage (laa) closure procedure was performed, and a 27mm watchman flx closure device was successfully implanted on (b)(6) 2024.The patient was discharged.During a routine 45-day follow-up on (b)(6) 2024, it was noted there was a leak due to closure device shifting.No information was provided at that time.The leak was below the fabric and had not endothelialized.A computed tomography (ct) was performed after multiple transesophageal echocardiography's.The patient remains on warfarin.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX?
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key24377820
Report Number2124215-2026-09039
Device Sequence Number11980711
Product Code NGV
UDI-Device Identifier08714729860501
UDI-Public(01)08714729860501(17)261019(10)32678263
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/26/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberM635WU50270
Device Catalogue NumberM635WU50270
Device Lot Number0032678263
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/04/2026
Supplement Date Received by Manufacturer03/25/2026
Initial Report FDA Received Date02/18/2026
Supplement Report FDA Received Date03/26/2026
Date Device Manufactured10/20/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age77 YR
Patient SexFemale
-
-